Ibrahim, Ailen Hazel O.
HRN: 21-66-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2022
CEFUROXIME 1.5GM (VIAL)
08/13/2022
08/13/2022
IV
1.5 Grams
LD
For Repeat CS Due To CPD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueIntra-abdominalReproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes